The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer

Tadashi Uehara, Tokujiro Yano, Shinji Kuninaka, Ichiro Yoshino, Hiroshi Asoh, Yukito Ichinose

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background and Objectives: It is not clear whether postoperative inflammation affects the prognosis of malignant disease. Methods: We retrospectively reviewed the patients with non-small-cell lung cancer who underwent a complete resection at the National Kyushu Cancer Center from 1989 to 1996. For the treatment of prolonged air leakage after a pulmonary lobectomy, 25 patients received an intrapleural injection of OK-432, a lyophilized preparation of the heat- and penicillin-treated Su-strain of the Streptococcus pyogenes group A3. All patients were males who were older than 50 years of age. As a control, we selected 164 male patients who were older than 50 years of age and not given OK-432 during the same period. Results: The administration of OK-432 in most patients was performed on the 4th day after the operation. Pleural drainage could be terminated in a mean of 5.5 days after the intrapleural administration of OK-432. In the control group, the serum C-reactive protein (CRP) level reached a peak on day 4 after the operation and returned to almost a normal level on day 14 after the operation. In the OK-432 group, the peak CRP level, which was significantly higher than that in the control group, was observed on day 7 after the operation and the elevated CRP level was maintained until 28 days after the operation. The mean level of CRP in the OK-432 group was significantly higher than that in the control on days 7, 14, and 28 after the operation. No significant difference was observed in the disease-free survivals between the 2 groups. Conclusions: Based on the above findings, postoperative prolonged inflammation does not seem to affect the progression of subclinically residual tumor cells. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)51-54
Number of pages4
JournalJournal of Surgical Oncology
Volume75
Issue number1
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Picibanil
Non-Small Cell Lung Carcinoma
Inflammation
C-Reactive Protein
Control Groups
Streptococcus pyogenes
Residual Neoplasm
Penicillins
Disease-Free Survival
Blood Proteins
Drainage
Hot Temperature
Air
Lung
Injections
Neoplasms

Keywords

  • Non-small-cell lung cancer
  • OK-432
  • Postoperative inflammation

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer. / Uehara, Tadashi; Yano, Tokujiro; Kuninaka, Shinji; Yoshino, Ichiro; Asoh, Hiroshi; Ichinose, Yukito.

In: Journal of Surgical Oncology, Vol. 75, No. 1, 2000, p. 51-54.

Research output: Contribution to journalArticle

Uehara, Tadashi ; Yano, Tokujiro ; Kuninaka, Shinji ; Yoshino, Ichiro ; Asoh, Hiroshi ; Ichinose, Yukito. / The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer. In: Journal of Surgical Oncology. 2000 ; Vol. 75, No. 1. pp. 51-54.
@article{180a1b7f07bf4028a1b599ccf90fd2e3,
title = "The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer",
abstract = "Background and Objectives: It is not clear whether postoperative inflammation affects the prognosis of malignant disease. Methods: We retrospectively reviewed the patients with non-small-cell lung cancer who underwent a complete resection at the National Kyushu Cancer Center from 1989 to 1996. For the treatment of prolonged air leakage after a pulmonary lobectomy, 25 patients received an intrapleural injection of OK-432, a lyophilized preparation of the heat- and penicillin-treated Su-strain of the Streptococcus pyogenes group A3. All patients were males who were older than 50 years of age. As a control, we selected 164 male patients who were older than 50 years of age and not given OK-432 during the same period. Results: The administration of OK-432 in most patients was performed on the 4th day after the operation. Pleural drainage could be terminated in a mean of 5.5 days after the intrapleural administration of OK-432. In the control group, the serum C-reactive protein (CRP) level reached a peak on day 4 after the operation and returned to almost a normal level on day 14 after the operation. In the OK-432 group, the peak CRP level, which was significantly higher than that in the control group, was observed on day 7 after the operation and the elevated CRP level was maintained until 28 days after the operation. The mean level of CRP in the OK-432 group was significantly higher than that in the control on days 7, 14, and 28 after the operation. No significant difference was observed in the disease-free survivals between the 2 groups. Conclusions: Based on the above findings, postoperative prolonged inflammation does not seem to affect the progression of subclinically residual tumor cells. (C) 2000 Wiley-Liss, Inc.",
keywords = "Non-small-cell lung cancer, OK-432, Postoperative inflammation",
author = "Tadashi Uehara and Tokujiro Yano and Shinji Kuninaka and Ichiro Yoshino and Hiroshi Asoh and Yukito Ichinose",
year = "2000",
doi = "10.1002/1096-9098(200009)75:1<51::AID-JSO9>3.0.CO;2-F",
language = "English",
volume = "75",
pages = "51--54",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer

AU - Uehara, Tadashi

AU - Yano, Tokujiro

AU - Kuninaka, Shinji

AU - Yoshino, Ichiro

AU - Asoh, Hiroshi

AU - Ichinose, Yukito

PY - 2000

Y1 - 2000

N2 - Background and Objectives: It is not clear whether postoperative inflammation affects the prognosis of malignant disease. Methods: We retrospectively reviewed the patients with non-small-cell lung cancer who underwent a complete resection at the National Kyushu Cancer Center from 1989 to 1996. For the treatment of prolonged air leakage after a pulmonary lobectomy, 25 patients received an intrapleural injection of OK-432, a lyophilized preparation of the heat- and penicillin-treated Su-strain of the Streptococcus pyogenes group A3. All patients were males who were older than 50 years of age. As a control, we selected 164 male patients who were older than 50 years of age and not given OK-432 during the same period. Results: The administration of OK-432 in most patients was performed on the 4th day after the operation. Pleural drainage could be terminated in a mean of 5.5 days after the intrapleural administration of OK-432. In the control group, the serum C-reactive protein (CRP) level reached a peak on day 4 after the operation and returned to almost a normal level on day 14 after the operation. In the OK-432 group, the peak CRP level, which was significantly higher than that in the control group, was observed on day 7 after the operation and the elevated CRP level was maintained until 28 days after the operation. The mean level of CRP in the OK-432 group was significantly higher than that in the control on days 7, 14, and 28 after the operation. No significant difference was observed in the disease-free survivals between the 2 groups. Conclusions: Based on the above findings, postoperative prolonged inflammation does not seem to affect the progression of subclinically residual tumor cells. (C) 2000 Wiley-Liss, Inc.

AB - Background and Objectives: It is not clear whether postoperative inflammation affects the prognosis of malignant disease. Methods: We retrospectively reviewed the patients with non-small-cell lung cancer who underwent a complete resection at the National Kyushu Cancer Center from 1989 to 1996. For the treatment of prolonged air leakage after a pulmonary lobectomy, 25 patients received an intrapleural injection of OK-432, a lyophilized preparation of the heat- and penicillin-treated Su-strain of the Streptococcus pyogenes group A3. All patients were males who were older than 50 years of age. As a control, we selected 164 male patients who were older than 50 years of age and not given OK-432 during the same period. Results: The administration of OK-432 in most patients was performed on the 4th day after the operation. Pleural drainage could be terminated in a mean of 5.5 days after the intrapleural administration of OK-432. In the control group, the serum C-reactive protein (CRP) level reached a peak on day 4 after the operation and returned to almost a normal level on day 14 after the operation. In the OK-432 group, the peak CRP level, which was significantly higher than that in the control group, was observed on day 7 after the operation and the elevated CRP level was maintained until 28 days after the operation. The mean level of CRP in the OK-432 group was significantly higher than that in the control on days 7, 14, and 28 after the operation. No significant difference was observed in the disease-free survivals between the 2 groups. Conclusions: Based on the above findings, postoperative prolonged inflammation does not seem to affect the progression of subclinically residual tumor cells. (C) 2000 Wiley-Liss, Inc.

KW - Non-small-cell lung cancer

KW - OK-432

KW - Postoperative inflammation

UR - http://www.scopus.com/inward/record.url?scp=0033798743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033798743&partnerID=8YFLogxK

U2 - 10.1002/1096-9098(200009)75:1<51::AID-JSO9>3.0.CO;2-F

DO - 10.1002/1096-9098(200009)75:1<51::AID-JSO9>3.0.CO;2-F

M3 - Article

C2 - 11025462

AN - SCOPUS:0033798743

VL - 75

SP - 51

EP - 54

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -